Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-23

FDA Approved: PRIMIDONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Primidone (generic) from Actavis Pharma, Inc., under ANDA083551.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMIDONE (Primidone)

Snippet

SUPPL AP for PRIMIDONE (PRIMIDONE)